Trials / Completed
CompletedNCT00827983
Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)
Efficacy and Tolerability of Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 683 (actual)
- Sponsor
- IBSA Institut Biochimique SA · Industry
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, open, randomised, parallel, multicentre, two arm trial comparing a new form of luteal support (S.C.) to an approved comparator (vaginal gel).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Progesterone | 25 mg, s.c., once à day |
| DRUG | Progesterone | 90 mg, vaginally, once à day |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2010-11-01
- Completion
- 2011-05-01
- First posted
- 2009-01-23
- Last updated
- 2013-01-31
- Results posted
- 2012-12-26
Locations
14 sites across 5 countries: Germany, Hungary, Italy, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00827983. Inclusion in this directory is not an endorsement.